GlassScriptPhysician profile
Matthew Morris Dedmon
NPI 1184910614
$15,916.58
in general payments reported to CMS, 2019-2025
8 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,296 · 2020: $80.54 · 2021: $342 · 2022: $347 · 2023: $2,336 · 2024: $11K · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,659 · Food and Beverage: $2,620 · Education: $1,571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,659.21 |
| Food and Beverage | $2,619.95 |
| Education | $1,571.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $14,898.94 | 2019-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Advanced Bionics, LLC | $487.26 | 2019-2021 | |
| Iotamotion, INC. | $204.70 | 2023 | Iotasoft Insertion System |
| Cochlear Americas | $153.92 | 2022-2023 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Oticon Medical, LLC | $74.56 | 2019-2024 | Ponto Bone Anchored Hearing System |
| Integra Lifesciences Corporation | $48.17 | 2023 | Integra, Instruments-Orthopedic, Microfrance |
| Stryker Corporation | $34.17 | 2021 | |
| Optinose US, INC. | $14.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Dedmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.